Annual CFF
$61.52 M
+$55.19 M+871.64%
December 31, 2023
Summary
- As of February 20, 2025, RXST annual cash flow from financing activities is $61.52 million, with the most recent change of +$55.19 million (+871.64%) on December 31, 2023.
- During the last 3 years, RXST annual CFF has risen by +$36.29 million (+143.78%).
- RXST annual CFF is now -55.20% below its all-time high of $137.34 million, reached on December 31, 2021.
Performance
RXST Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$878.00 K
-$110.59 M-99.21%
September 30, 2024
Summary
- As of February 20, 2025, RXST quarterly cash flow from financing activities is $878.00 thousand, with the most recent change of -$110.59 million (-99.21%) on September 30, 2024.
- Over the past year, RXST quarterly CFF has dropped by -$2.68 million (-75.35%).
- RXST quarterly CFF is now -99.27% below its all-time high of $120.55 million, reached on September 30, 2021.
Performance
RXST Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$123.91 M
+$9.11 M+7.94%
September 30, 2024
Summary
- As of February 20, 2025, RXST TTM cash flow from financing activities is $123.91 million, with the most recent change of +$9.11 million (+7.94%) on September 30, 2024.
- Over the past year, RXST TTM CFF has increased by +$62.38 million (+101.39%).
- RXST TTM CFF is now -23.17% below its all-time high of $161.27 million, reached on September 30, 2021.
Performance
RXST TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
RXST Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +871.6% | -75.3% | +101.4% |
| 3 y3 years | +143.8% | -75.3% | +101.4% |
| 5 y5 years | +4525.9% | -75.3% | +101.4% |
RXST Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -55.2% | +871.6% | -99.2% | +110.7% | -9.8% | >+9999.0% |
| 5 y | 5-year | -55.2% | +4525.9% | -99.3% | +110.7% | -23.2% | >+9999.0% |
| alltime | all time | -55.2% | +4525.9% | -99.3% | +110.7% | -23.2% | >+9999.0% |
RxSight Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $878.00 K(-99.2%) | $123.91 M(+7.9%) |
| Jun 2024 | - | $111.47 M(+1294.8%) | $114.79 M(+2626.0%) |
| Mar 2024 | - | $7.99 M(+124.4%) | $4.21 M(-93.2%) |
| Dec 2023 | $61.52 M(+871.6%) | $3.56 M(-143.3%) | $61.52 M(-4.3%) |
| Sep 2023 | - | -$8.23 M(-1024.1%) | $64.27 M(-10.8%) |
| Jun 2023 | - | $891.00 K(-98.6%) | $72.05 M(+0.4%) |
| Mar 2023 | - | $65.31 M(+935.4%) | $71.73 M(+1032.9%) |
| Dec 2022 | $6.33 M | $6.31 M(-1486.2%) | $6.33 M(+1376.0%) |
| Sep 2022 | - | -$455.00 K(-178.7%) | $429.00 K(-99.6%) |
| Jun 2022 | - | $578.00 K(-689.8%) | $121.43 M(-7.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$98.00 K(-124.3%) | $131.10 M(-4.5%) |
| Dec 2021 | $137.34 M(+444.2%) | $404.00 K(-99.7%) | $137.34 M(-14.8%) |
| Sep 2021 | - | $120.55 M(+1076.4%) | $161.27 M(+295.5%) |
| Jun 2021 | - | $10.25 M(+66.8%) | $40.77 M(+30.2%) |
| Mar 2021 | - | $6.14 M(-74.7%) | $31.31 M(+24.0%) |
| Dec 2020 | $25.24 M(+1797.5%) | $24.33 M(>+9900.0%) | $25.24 M(+2676.3%) |
| Sep 2020 | - | $52.00 K(-93.4%) | $909.00 K(+6.1%) |
| Jun 2020 | - | $782.00 K(+942.7%) | $857.00 K(+1042.7%) |
| Mar 2020 | - | $75.00 K | $75.00 K |
| Dec 2019 | $1.33 M | - | - |
FAQ
- What is RxSight annual cash flow from financing activities?
- What is the all time high annual CFF for RxSight?
- What is RxSight annual CFF year-on-year change?
- What is RxSight quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for RxSight?
- What is RxSight quarterly CFF year-on-year change?
- What is RxSight TTM cash flow from financing activities?
- What is the all time high TTM CFF for RxSight?
- What is RxSight TTM CFF year-on-year change?
What is RxSight annual cash flow from financing activities?
The current annual CFF of RXST is $61.52 M
What is the all time high annual CFF for RxSight?
RxSight all-time high annual cash flow from financing activities is $137.34 M
What is RxSight annual CFF year-on-year change?
Over the past year, RXST annual cash flow from financing activities has changed by +$55.19 M (+871.64%)
What is RxSight quarterly cash flow from financing activities?
The current quarterly CFF of RXST is $878.00 K
What is the all time high quarterly CFF for RxSight?
RxSight all-time high quarterly cash flow from financing activities is $120.55 M
What is RxSight quarterly CFF year-on-year change?
Over the past year, RXST quarterly cash flow from financing activities has changed by -$2.68 M (-75.35%)
What is RxSight TTM cash flow from financing activities?
The current TTM CFF of RXST is $123.91 M
What is the all time high TTM CFF for RxSight?
RxSight all-time high TTM cash flow from financing activities is $161.27 M
What is RxSight TTM CFF year-on-year change?
Over the past year, RXST TTM cash flow from financing activities has changed by +$62.38 M (+101.39%)